|
|||||
|
|
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators’ Consortium study (POE 10‐03) |
|
| Authors: | Todd M. Cooper Sharyn D. Baker Lie Li Amina Ahmed Tanya Trippett Lia Gore Margaret E. Macy Aru Narendran Keith August Michael J. Absalon Jessica Boklan Jessica Pollard Daniel Magoon Patrick A. Brown |
| Abstract: | |
| Keywords: | pediatric leukemia CXCR4 plerixafor tumor microenvironment |